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Abstract
Background: Canine leishmaniasis, a zoonotic disease caused by Leishmania infantum vectored by phlebotomine
sand flies, is considered a relevant veterinary and public health problem in various countries, namely in the
Mediterranean basin and Brazil, where dogs are considered the main reservoir hosts. Not only diseased dogs but also
those subclinically infected play a relevant role in the transmission of L. infantum to vectors; therefore, early diagnosis
is essential, under both a clinical and an epidemiological perspective. Molecular tools can be a more accurate and
sensitive approach for diagnosis, with a wide range of protocols currently in use. The aim of the present report was
to compare four PCR based protocols for the diagnosis of canine Leishmania infection in a cohort of dogs from the
Douro region, Portugal.
Results: A total of 229 bone marrow samples were collected from dogs living in the Douro region, an endemic region
for leishmaniasis. Four PCR protocols were evaluated for Leishmania DNA detection in canine samples, three single
(ITS1-PCR, MC-PCR and Uni21/Lmj4-PCR) and one nested (nested SSU rRNA-PCR). Two of the protocols were based
on nuclear targets and the other two on kinetoplastid targets. The higher overall percentage of infected dogs was
detected with the nested SSU rRNA-PCR (37.6%), which also was able to detect Leishmania DNA in a higher number
of samples from apparently healthy dogs (25.3%). The ITS1-PCR presented the lowest level of Leishmania detection.
Conclusions: Nested SSU rRNA-PCR is an appropriate method to detect Leishmania infection in dogs. Accurate and
early diagnosis in clinically suspect as well as apparently healthy dogs is essential, in order to treat and protect animals
and public health and contribute to the control and awareness of the disease.
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Introduction
Canine leishmaniasis (CanL), caused by the protozoan
parasite Leishmania infantum, is a veterinary medical
and public health problem in different Mediterranean
countries, namely those of southern Europe, and also
in Brazil, in which dogs are considered the primary
domestic reservoir host for the human infection.
According to Moreno & Alvar [1], it is estimated that
at least 2.5 million dogs are infected in south-western
Europe. In addition, there is an evident northward
expansion of CanL in Europe, as demonstrated by
epidemiological studies in countries from the eastern
part of the continent [2].
Currently, laboratorial diagnosis of CanL is usually
performed by direct parasitological examination and/or
serological methods, which are time consuming and may
lack accuracy. Therefore, more sensitive and specific
methods, namely molecular diagnostic tools, are essen-
tial to detect Leishmania infection, both in clinically sus-
pected and apparently healthy dogs, since the latter
group can also be a source of the parasite to the phlebo-
tomine vectors [3]. According to a recent meta-analysis
on CanL carried out in Iran, most infected dogs pre-
sented no clinical signs [4].
The polymerase chain reaction (PCR) is nowadays a
simple and valid molecular tool to detect Leishmania
spp. in different clinical samples, as well as to identify
the parasite species, strains and genotypes [5]. There are
currently a large number of protocols with sensitivities
and specificities that depend on different factors such as
the DNA extraction method, clinical material, primers,
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target copy numbers, and technical conditions [6]. With
PCR, diagnosis of CanL has shown a considerable im-
provement, with sensitivities of 90–100% in clinically
suspected or parasitological confirmed cases (reviewed
in [6]). However, when dealing with early diagnosis and
the detection of parasite in subclinical cases, which can
reach 80% of dogs [7], sensitivity might be much lower.
In this study, we compared four PCR based proto-
cols using different DNA targets (small sub-unit
rRNA gene, ITS-1 and kDNA) with Novy-MacNeal-
Nicolle (NNN) culture in a cohort of dogs from a re-
gion of Portugal where leishmaniasis is endemic. All
the protocols used were previously established in
IHMT for the diagnosis of human leishmaniasis.
However, for the diagnosis of CanL only MC-PCR has
been used, with no comparison of performances made
before. Under these circumstances, we aimed at
selecting an appropriate method for the detection of
Leishmania canine infections.
Methods
Between July 2011 and October 2012, 229 bone marrow
samples were collected from dogs housed in two Animal
Municipal Centres in the Douro region, a geographical
area where CanL is endemic in Portugal. After physical
examination and depending on the presence of clinical
manifestations compatible with the disease, such as
weight loss, alopecia, lymphadenomegaly, lethargy, pale
mucosae and skin lesions [8], the animals were charac-
terized as clinically suspected, i.e. presenting clinical
signs (n = 150) or apparently healthy, i.e. with no clinical
signs (n = 79). Bone marrow samples were obtained from
the osteochondral joint of the sixth to the ninth ribs,
and placed into EDTA tubes and further divided into
two parts: one for NNN culture, as described by Maia &
Campino [9], and the other one for DNA extraction
using a commercial kit (PCR Template Preparation Kit,
Roche, Germany).
The presence of Leishmania DNA was evaluated by
four PCR protocols using different DNA targets, as de-
scribed in Table 1: (i) nested PCR using the variable part
of the small sub-unit rRNA gene (nested SSU rRNA-
PCR); (ii) ribosomal internal transcribed spacer 1 (ITS1-
PCR); (iii and iv) kinetoplastid minicircle sequences
(MC-PCR; Uni21/Lmj4-PCR). In order to assure DNA
integrity, a PCR using the canine β-actin gene was
performed using 2 μl of DNA, 10 pmol of each primer
(5'-TGA CGG GGT CAC CCA CAC TGT GCC CAT
CTA-3' and 5'-CTA GAA GCA TTG CGG TGG ACG
ATG GAG GG-3'), 1U de Taq polymerase and buffer 1×
(Promega, Madison, WI, USA), 1.5 mM MgCl2, 0.2 mM
dNTPs (Bioline, London, UK), under the following
conditions: 40 cycles each denaturation at 94 °C (30 s),
annealing at 64 °C (30 s) and extension at 72 °C (30 s).
The amplified products presented a fragment of 283 bp.
The Z-test for absolute difference between two pro-
portions was used to compare proportions by means of
the StatLib free software, with a probability P-value <
0.05 being considered as statistically significant.
Results and discussion
A significant percentage of positive samples was found
with the nested SSU rRNA-PCR protocol (37.6%, P <
0.001; Table 2). Moreover, with this protocol we detected
a higher percentage of positive samples in apparently
healthy dogs (25.3%) than with the other tested
Table 1 PCR protocols used for Leishmania detection in dog samples





Nested SSU rRNA-PCR 1st PCR:
R221: GGTTCCTTTCCTGATTTACG
R332: GGCCGGTAAAGGCCGAATAG
603 10 μl DNA, 2 mM MgCl2,
0.2 mM dNTPs, 15 pmol primers,
1.4U Taq, 1× buffer (Promega)
den.: 94 °C (30'); ann.:






358 5 μl 1st PCR proda., 2 mM MgCl2,
0.2 mM dNTPs, 1.5 pmol primers,
0.7U Taq, 1× buffer (Promega)
den.: 94 °C (30'); ann.:





311 2 μl DNA, 1.5 mM MgCl2,
0.2 mM dNTPs, 25 pmol primers,
1U Taq, 1× buffer (Promega)
den.: 95 °C (20'); ann.:





447 2 μl DNA, 3 mM MgCl2,
0.2 mM dNTPs, 15 pmol primers,
1U Taq, 1× buffer (Promega)
den.: 94 °C (30'), ann.:





800 2 μl DNA, 1.5 mM MgCl2,
25 pmol primers,
12,5 μl Biomix (Bioline)
den.: 94 °C (30), ann.:
62 °C (30'); ext.: 72 °C (45');
35 cycles
[36]
Abbreviations: bp base pairs, den. denaturation, ann. annealing, ext. extension, prod. product, PCR polymerase chain reaction, MC minicircle, ITS1 internal
transcribed spacer 1, rRNA ribosomal RNA gene, SSU small subunit
aPCR product was previously diluted 1:200 in ultra-pure water
bUni21 primer based on a conserved region of a Leishmania major kinetoplastid minicircle sequence, and Lmj4 based on the variable region of the same L.
major sequence
Albuquerque et al. Parasites & Vectors  (2017) 10:57 Page 2 of 5
protocols, a fact that strongly suggests it to be a more
adequate tool for detection of Leishmania, especially in
subclinically infected dogs. These molecular markers are
able to identify Leishmania parasites at the genus level.
This same protocol was previously shown to have high
sensitivity and to be a useful tool for human leishmania-
sis diagnosis, monitoring the success of treatment, and
predicting relapses in patients with HIV infection [10].
Nevertheless, this methodology, which involves a second
PCR step, may be prone to contamination among
samples, thus requiring higher attention in performing
dilution of the first amplicons and in the second PCR
step. The analysis of all positive samples along with
intercalated known negative samples was repeated in
order to exclude potential contaminations.
ITS1-PCR presented the lowest number of positive
samples (8.7%; Table 2). As for the nested SSU rRNA-
PCR protocol, this one also detects Leishmania at the
genus level. This limitation regarding the non-
distinction at the species level can be critical in regions
where more than one Leishmania spp. is present. When
using the ITS1 marker, an additional RFLP analysis
should be performed for species identification [5]. How-
ever, it may not be the most appropriate method, as it
does not differentiate within the L. donovani complex
[11]. Therefore, sequencing should be used as comple-
mentary to this analysis [12].
Kinetoplastid MC-PCR protocol was able to detect
and identify Leishmania at the complex level. This
protocol, with primers targeted to a kinetoplastid mini-
circle sequence of the Leishmania donovani complex
[13], allowed the identification of 33 positive samples
(14.4%; Table 2), mainly in clinically suspected dogs
(18.7%, P = 0.012; Table 2).
In Uni21/Lmj4-PCR protocol, the primer pair Uni21/
Lmj4 was developed based on a Leishmania major mini-
circle kinetoplastid sequence. This protocol, based on
species-specific differences in amplicons size, differenti-
ate Old World Leishmania species, namely L. infantum.
Although with the same overall percentage of positive
samples as the MC-PCR, this method allowed the detec-
tion of Leishmania DNA in a higher number of appar-
ently healthy dogs.
The NNN culture detected only three positive bone
marrow samples. Out of these, IMT 401 (MCAN/PT/
13/IMT401) was sent to the Centre National de Référ-
ence des Leishmanioses (Montpellier, France) and typed
by multilocus enzyme electrophoresis (MLEE) [14] as L.
infantum MON-1, the most common zymodeme in both
humans and dogs in the Mediterranean basin [15]. The
low sensitivity of cultural parasitological techniques has
also been described by other authors [16, 17]. Moreover,
cultures are prone to contamination and may take up to
4 weeks to provide a definitive diagnosis. These limita-
tions reinforce the need for more sensitive techniques
for the diagnosis of this disease, as is the case with
molecular diagnostic PCR techniques.
Simple PCR methods targeting kDNA minicircles
have been described as having higher sensitivity than
SSU rRNA-PCR in human samples. However, the im-
provement of the latter, by using a nested approach,
may increase its sensitivity, further allowing full spe-
cies identification when combined with sequencing
analysis [18].
The large number of subclinical Leishmania infections
in dogs has been well proven in epidemiological studies
worldwide, mainly by using serological methods but also
with advanced molecular methods [4, 19]. In the Douro
region, Cardoso et al. [20] highlighted this high percent-
age of subclinical infections and found that out of 60
seropositive animals, 51 (85%) had no clinical signs com-
patible with CanL. Similar results were found in other
geographic areas of the Mediterranean basin, particularly
in France, Italy, Spain, central and southern Portugal,
Turkey, and also in Brazil [21–26].
The high proportion of no patent disease may be
related to the development of some level of cellular
immune response, characterized by the production of
Th1 cytokines, such as IFN-γ, IL-2 and TNF-α, which is
known to limit the progression of the infection [27, 28].
Additionally, these apparently healthy dogs can act as
reservoirs, leading to the spread of infection with in-
creases in both canine prevalence and human incidence.
Thus, reinforcing control measures as well as perform-
ing effective clinical management, by using sensitive mo-
lecular methods in animals with and without clinical
signs, could improve diagnosis of the disease at an early
stage [3, 29, 30].
It has already been described that infectiousness in-
creases in dogs with clinical signs, as there is a higher
probability of transmission of the parasites to the
Table 2 Positive samples, analysed by the different PCR
protocols, from 150 dogs clinically suspected of leishmaniasis
and from 79 apparently healthy dogs







Nested SSU rRNA-PCR 66 (44.0)a 20 (25.3)a 86 (37.6)d,e,f
ITS1-PCR 18 (12.0)b 2 (1.3)b 20 (8.7)d
MC-PCR 28 (18.7)c 5 (6.3)c 33 (14.4)e
Uni21/Lmj4-PCR 23 (15.3) 10 (12.7) 33 (14.4)f
Abbreviations: AH apparently healthy, CS clinically suspected, ITS1 internal
transcribed spacer 1, MC minicircle, PCR polymerase chain reaction, rRNA
ribosomal RNA gene, SSU small subunit, Uni21/Lmj4 Uni21 primer based on
a conserved region of a Leishmania major kinetoplastid minicircle sequence,
and Lmj4 based on the variable region of the same L. major sequence
Only statistically significant differences are shown: aZ = 2.76, P = 0.006;
bZ = 2.41, P = 0.016; cZ = 2.53, P = 0.012; dZ = 7.31, P < 0.001; e,fZ = 5.65, P < 0.001
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phlebotomine vectors and spreading of CanL, than in
apparently healthy dogs. However, it is imperative to
stress that the latter ones may also contribute to parasite
transmission [3, 31, 32].
This study showed, from the four tested protocols,
that nested SSU rRNA-PCR was the most appropriate to
detect Leishmania infection in dogs, especially in sub-
clinical cases. Although only 44% of the positive samples
were detected by nested SSU rRNA-PCR in bone mar-
row of clinical suspected dogs, it is important to note
that the use of this biological sample for diagnosis of
CanL is not a consensus. It has been described that the
use of other samples such as peripheral blood, skin or
conjunctiva could be more appropriate [16, 22]. On the
other hand, it is possible that the threshold limit of the
PCR test might be below the detection level as amasti-
gotes tend to disseminate to other organs or even due to
“parasite silencing” caused by the host defence mecha-
nisms [33].
Conclusions
From an epidemiological point of view, for diagnosis of
canine Leishmania infection, it is of extreme relevance
the selection of an appropriate type of biological mater-
ial as well as an adequate protocol. Furthermore, in
order to contribute to the control of leishmaniasis in
dogs and humans, actions should be directed to both
dogs with and without clinical signs of leishmaniasis and
also to increase the awareness of dog owners regarding
the implementation of prophylactic measures.
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